[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354097-105":59,"doc-detail-354097-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","systematic-multiplatform-discovery-of-methylation-markers-enables-non-invasive-early-detection-of-endometrial-cancer-original-article","Systematic Multiplatform Discovery of Methylation Markers Enables Non-Invasive Early Detection of Endometrial Cancer - Original Article","","Endometrial cancer is the most common gynecological malignancy, yet lacks suitable noninvasive diagnostic tools because hysteroscopy and biopsy are invasive and unsuitable for routine screening. A multilayer marker discovery workflow integrated whole-genome bisulfite sequencing and targeted methylation panels across tumor and control tissues, followed by candidate prioritization for detection in cervical exfoliated cells. A two-stage design built and validated a qMSP methylation–specific PCR model in ThinPrep Cytology Test (TCT) samples using discovery and independent validation cohorts, identifying a three-gene panel for high-accuracy early detection and stage I detection support.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-multiplatform-discovery-of-methylation-markers-enables-non-invasive-early-detection-of-endometrial-cancer-original-article/354097/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-multiplatform-discovery-of-methylation-markers-enables-non-invasive-early-detection-of-endometrial-cancer-original-article/354097.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is noninvasive early detection of endometrial cancer still needed?","Question",{"text":113,"@type":114},"Current approaches rely on invasive procedures such as hysteroscopy and biopsy, and symptom-based triage lacks specificity. There is no standardized, widely endorsed early-detection method or tumor marker threshold, creating a clear clinical unmet need.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the methylation marker discovery workflow designed?",{"text":118,"@type":114},"The study used a multilayer workflow combining whole-genome bisulfite sequencing and targeted methylation panels in tumor and control tissues. Candidates were then prioritized and optimized for detection in cervical exfoliated cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What results did the validated qMSP model and three-gene panel achieve?",{"text":122,"@type":114},"The model showed strong performance in the validation cohort, with high sensitivity and specificity across premenopausal and postmenopausal subgroups. It also achieved a 92.86% detection rate for stage I endometrial cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354097,1790558318,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nClinical Research  \nSystematic Multiplatform Discovery of Methylation Markers Enables Non-Invasive Early Detection of Endometrial Cancer  \nYan Cai1 | Shuchao Chen2 | Zhen Wu2 | Jinxia Guan2 | Jie Zhao2  | Jianwei Ye2 | Baochen Du2 | Xiaoliang Han2 | Tong Shu1 | Guangpeng Zhou2 | Hong Zheng1  \n1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gynecologic Oncology, Peking University Cancer Hospital & Institute, Beijing, China | 2BioChain (Beijing) Science & Technology Inc. , Beijing, China  \nCorrespondence: Tong Shu ([shutong227@hotmail.com](shutong227@hotmail.com)) | Guangpeng Zhou ([zhou.guangpeng@biochainbj.com](zhou.guangpeng@biochainbj.com)) | Hong Zheng (zhhong306@hotmail. com)  \nReceived: 7 September 2025 | Revised: 29 December 2025 | Accepted: 28 January 2026  \nKeywords: DNA methylation | early detection | EC diagnostic model | endometrial cancer | TCT sample  \nABSTRACT  \nEndometrial cancer, the most common gynecological malignancy with an annual increase of 1%–3%, lacks suitable noninvasive diagnostic tools, as current methods like hysteroscopy and biopsy are invasive and impractical for routine screening. We conducted a comprehensive, multilayered marker discovery workflow integrating whole-genome bisulfite sequencing and targeted methylation panels in tumor and control tissues, then prioritized and optimized candidates for detection in cervical exfoliated cells. Using a two-stage design, we built and tested a quantitative methylation–specific PCR (qMSP) model in ThinPrep Cytology Test (TCT) samples, with 148 samples for discovery/model construction and an independent cohort of 80 TCT samples for validation. We identified a three-gene methylation panel—ZNF626, GRIA4, and SPDYA—that demonstrated high accuracy for early endometrial cancer detection from cervical cytology. In the validation cohort, the model showed strong performance across menopausal subgroups: in premenopausal women, sensitivity was 90.91% and specificity for benign endometrial disease was 92.59%; in postmenopausal women, sensitivity and specificity were 96.55% and 84.62%, respectively. Notably, the approach achieved a 92.86% detection rate for stage I endometrial cancer. These results support a robust, noninvasive diagnostic strategy that leverages simple cervical cytology sampling to enable early detection, facilitate clinical decision-making, and potentially improve outcomes for patients at risk of endometrial cancer.  \n1 | Introduction  \nEndometrial cancer (EC) is a prevalent malignancy of the female reproductive system, predominantly affecting peri- and postmenopausal women. Over the past two decades, its incidence has steadily increased, with a notable shift toward younger onset, likely reflecting rising life expectancy and lifestyle factors. In 2022, 420,368 new cases were reported worldwide [1, 2] . In  \nmany European and North American countries, EC is now the most frequently diagnosed gynecologic malignancy [1] . According to the National Cancer Center of China, there were approximately 77,700 new EC cases and 13,500 deaths in China in 2022, corresponding to an incidence of 11.25 per 100,000 and ranking second among gynecologic cancers after cervical cancer [3]. For patients with stage IA disease, surgery alone is often curative [4]. In contrast, advanced disease typically necessitates  \n\n| Abbreviations: BE, benign endometrium; CC, cervical cancer; DMR, Differential methylation region; EC, Uterine Corpus Endometrial Cancer; NE, normal endometrium; OC, ovarian cancer; PBL, peripheral blood leukocytes; qMSP, quantitative methylation-specific polymerase chain reaction; TCT, Thinprep Cytologic Test.\u003Cbr>Yan Cai, Shuchao Chen, and Zhen Wu have contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any","cbCait7v68gLlloN","https://ap.wps.com/l/cbCait7v68gLlloN","pdf",2839337,"English","# Introduction\n## Clinical need and current detection limitations\n## Molecular biomarker advances and DNA methylation rationale\n# Materials and Methods\n## Multiplatform marker discovery workflow\n## qMSP model development and validation design\n# Results\n## Three-gene methylation panel performance\n## Sensitivity and specificity across menopausal subgroups\n## Stage I detection performance\n# Discussion\n## Clinical implications for decision-making and outcome improvement","[{\"question\":\"Why is noninvasive early detection of endometrial cancer still needed?\",\"answer\":\"Current approaches rely on invasive procedures such as hysteroscopy and biopsy, and symptom-based triage lacks specificity. There is no standardized, widely endorsed early-detection method or tumor marker threshold, creating a clear clinical unmet need.\"},{\"question\":\"How was the methylation marker discovery workflow designed?\",\"answer\":\"The study used a multilayer workflow combining whole-genome bisulfite sequencing and targeted methylation panels in tumor and control tissues. Candidates were then prioritized and optimized for detection in cervical exfoliated cells.\"},{\"question\":\"What results did the validated qMSP model and three-gene panel achieve?\",\"answer\":\"The model showed strong performance in the validation cohort, with high sensitivity and specificity across premenopausal and postmenopausal subgroups. It also achieved a 92.86% detection rate for stage I endometrial cancer.\"}]","Systematic Multiplatform Discovery of Methylation Markers Enables Non-Invasive Early Detection of Endometrial Cancer - Original Article | PDF",1790108916,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e1884c914a682e6094fb81a1dd1cccb.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8477bc45f6ac52713918691f4a63eae.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a332f041b3f60da1f96944735dd6410.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca7e0ae2733c275719950bb39f704441.webp",980,1287]